Susquehanna International Group’s Structure Therapeutics GPCR Stock Holding History

Susquehanna International Group’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69M	Buy	55,842 +46,843	+521%	+$3.21M	﹤0.01%	5501
2025 Q4	$626K	Sell	8,999 -204,609	-96%	-$8.35M	﹤0.01%	8283
2025 Q3	$5.98M	Buy	213,608 +137,806	+182%	+$2.74M	﹤0.01%	3803
2025 Q2	$1.57M	Buy	75,802 +7,635	+11%	+$168K	﹤0.01%	6318
2025 Q1	$1.18M	Sell	68,167 -36	-0.1%	-$882	﹤0.01%	6840
2024 Q4	$1.85M	Buy	68,203 +4,422	+7%	+$157K	﹤0.01%	5498
2024 Q3	$2.8M	Sell	63,781 -55,837	-47%	-$2.16M	﹤0.01%	4673
2024 Q2	$4.7M	Buy	119,618 +37,826	+46%	+$1.55M	﹤0.01%	3543
2024 Q1	$3.51M	Buy	81,792 +70,090	+599%	+$2.96M	﹤0.01%	4221
2023 Q4	$477K	Buy	+11,702	New	+$671K	﹤0.01%	8788

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Susquehanna International Group's GPCR Position: Q1 2026 in Review

Susquehanna International Group increased its Structure Therapeutics (GPCR) stake by 521% in Q1 2026, buying an estimated $3.21M and bringing the position to 55,842 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #5501.

Susquehanna International Group first reported a position in GPCR in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.98M in Q3 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

Susquehanna International Group held 55,842 shares of Structure Therapeutics worth $2.69M as of Q1 2026.
Susquehanna International Group bought 46,843 Structure Therapeutics shares in Q1 2026, an estimated $3.21M.
Structure Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5501 holding.
Susquehanna International Group first reported a position in Structure Therapeutics in Q4 2023 and has held it in 10 quarters since.
Susquehanna International Group's Structure Therapeutics position peaked at $5.98M in Q3 2025.
196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.